Elevated AD biomarkers do not explain cognitive performance in a community-recruited clinical trial cohort.
Saved in:
| Title: | Elevated AD biomarkers do not explain cognitive performance in a community-recruited clinical trial cohort. |
|---|---|
| Authors: | Landau SM; University of California Berkeley, Berkeley, California, USA.; Department of Veterans Affairs Medical Center, Center for Imaging of Neurodegenerative Diseases, San Francisco, San Francisco, California, USA., Liu P; University of California Berkeley, Berkeley, California, USA., Harrison TM; University of California Berkeley, Berkeley, California, USA., Taggett J; University of California Berkeley, Berkeley, California, USA., Ward TJ; University of California Berkeley, Berkeley, California, USA., Murphy A; University of California Berkeley, Berkeley, California, USA., Lockhart SN; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Lovato LC; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Koeppe R; University of Michigan, Ann Arbor, Michigan, USA., Farias ST; University of California Davis, Davis, California, USA., Papp KV; Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA., Snyder HM; Alzheimer's Association, Chicago, Illinois, USA., Harvey DJ; University of California Davis, Davis, California, USA., Espeland M; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Maillard P; University of California Davis, Davis, California, USA., DeCarli C; University of California Davis, Davis, California, USA., Vemuri P; Mayo Clinic, Rochester, Minnesota, USA., Weiner M; Department of Veterans Affairs Medical Center, Center for Imaging of Neurodegenerative Diseases, San Francisco, San Francisco, California, USA.; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA., Baker LD; Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA., Jagust WJ; University of California Berkeley, Berkeley, California, USA. |
| Corporate Authors: | U.S. POINTER Study Group and Alzheimer's Disease Neuroimaging Initiative |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2026 May; Vol. 22 (5), pp. e71472. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.71472 |
